ASLN ASLN

ASLAN Pharmaceuticals Share Price

FREE ASLN REPORT

0.74
0.01 (1.37%)
Upgrade to Real-Time
Regular Market
0.74
Volume 52,140
Bid Price 0.74
Ask Price 0.7449
News -
Company Name Stock Ticker Symbol Market Type
ASLAN Pharmaceuticals Ltd ASLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.01 1.37% 0.74 15:56:51
Open Price Low Price High Price Close Price Prev Close
0.7316 0.71 0.745 0.73
Trades Volume VWAP Dollar Volume Avg Volume
185 52,140  0.7291822  38,020 -
Last Trade Time Type Quantity Stock Price Currency
15:58:13 100  0.74 USD

Period:

Draw Mode:

ASLAN Pharmaceuticals Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 51.61M 69.74M 69.74M  -  - -0.45 -1.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News ASLAN Pharmaceuticals

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

ASLN Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.